FEDERAL PHARMACEUTICALS LIMITED – Trademark Portfolio
Entity Type: 22
FEDERAL PHARMACEUTICALS LIMITED has 3 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 3 are successfully registered — a 100% registration rate. The portfolio includes marks such as RE LIERRE. Filings span 3 Nice Classification classes, with the highest activity in Class 3 (Cosmetics & Cleaning) and Class 10 (Medical Apparatus). This trademark owner is based in HONG KONG.
3/F,WORKINGTON TOWER, 78 BONHAM STRAND,SHEUNG WAN
HONG KONG , CN
Showing of trademarks Trademarks
Trademark Classifications
FEDERAL PHARMACEUTICALS LIMITED's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does FEDERAL PHARMACEUTICALS LIMITED have?
FEDERAL PHARMACEUTICALS LIMITED has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does FEDERAL PHARMACEUTICALS LIMITED file in?
FEDERAL PHARMACEUTICALS LIMITED files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are FEDERAL PHARMACEUTICALS LIMITED's most well-known trademarks?
FEDERAL PHARMACEUTICALS LIMITED's registered trademark portfolio includes well-known marks such as RE LIERRE. These are among 3 currently registered trademarks in the portfolio.
What is FEDERAL PHARMACEUTICALS LIMITED's trademark registration success rate?
FEDERAL PHARMACEUTICALS LIMITED has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.